TCTR20201224003尚未招募3 期
Association between TTR-INR guided warfarin adjustment protocol and time in therapeutic range (TTR) in patients with atrial fibrillation receiving vitamin K antagonist oral anticoagulant
Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 150 人开始时间: 2020年12月24日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Adult patients (age ≥18 years)
- •2. Followed up at warfarin clinic in KCMH
- •3. Diagnosed with non-valvular atrial fibrillation (confirmed by 12-lead ECG or ECG strip with ≥30 seconds of AF, including wearable-recorded ECGs)
- •4. Using warfarin for at least 2 years
- •5. Have at least 3 INR per year readings previously for TTR calculation
排除标准
- •1. Rheumatic mitral valve disease
- •2. Prosthetic valve or valve repair
- •3. Atrial fibrillation related to transient reversible cause (e.g., during respiratory tract infection)
- •4. Participation in any other clinical trial
- •5. Pregnancy
- •6. History of use DOACs within 2 years
- •7. Not available to attend follow-up
- •8. Refusal to participate
研究者
相似试验
已完成
不适用
The Influence of Preoperative Warfarin Medication on Thromboelastography and Blood TransfusionAtrial FibrillationNCT02191449Konkuk University Medical Center107
已完成
不适用
Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and CephalosporinsAtrial FibrillationPulmonary EmbolismVenous ThrombosisNCT01857050Meir Medical Center236
招募中
4 期
Outcomes of Warfarin and Rivaroxaban (Xalerban) consumption in patients with Atrial fibrillatioIRCT20170530034232N2Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences330
Unknown
不适用
Excessive Warfarin Anticoagulation - Causes and ConsequencesAnticoagulationNCT02761941University of Turku25,000
已完成
4 期
Influenza Vaccination and Oral Anticoagulant TherapyAnticoagulantsInfluenza VaccinesNCT00222638University Of Perugia100